From: Differential expression of centrosomal proteins at different stages of human glioma
Group | ||||||
---|---|---|---|---|---|---|
mRNA | Low-grade glioma (n= 11) | High-grade glioma (n= 23) | p-value | |||
hNinein isoform 1 | Absent | 0 | (0%) | 1 | (4.3%) | 0.741 |
Rare | 9 | (81.8%) | 13 | (56.5%) | ||
Moderate | 2 | (18.2%) | 8 | (34.8%) | ||
Abundant | 0 | (0%) | 1 | (4.3%) | ||
hNinein isoform 2 | Absent | 2 | (18.2%) | 0 | (0%) | 0.254 |
Rare | 7 | (63.6%) | 18 | (78.3%) | ||
Moderate | 2 | (18.2%) | 4 | (17.4%) | ||
Abundant | 0 | (0%) | 1 | (4.3%) | ||
hNinein isoform 5 | Absent | 1 | (9.1%) | 0 | (0%) | 0.501 |
Rare | 8 | (72.7%) | 15 | (65.2%) | ||
Moderate | 2 | (18.2%) | 7 | (30.4%) | ||
Abundant | 0 | (0%) | 1 | (4.3%) | ||
hNinein isoform 6 | Absent | 3 | (27.3%) | 14 | (60.9%) | 0.141 |
Rare | 8 | (72.7%) | 9 | (39.1%) | ||
Moderate | 0 | (0%) | 0 | (0%) | ||
Abundant | 0 | (0%) | 0 | (0%) | ||
γ-tubulin | Absent | 0 | (0%) | 0 | (0%) | 0.005* |
Rare | 9 | (81.8%) | 5 | (21.7%) | ||
Moderate | 2 | (18.2%) | 14 | (60.9%) | ||
Abundant | 0 | (0%) | 4 | (17.4%) | ||
Aurora A | Absent | 3 | (27.3%) | 0 | (0%) | 0.030* |
Rare | 8 | (72.7%) | 20 | (87.0%) | ||
Moderate | 0 | (0%) | 3 | (13.0%) | ||
Abundant | 0 | (0%) | 0 | (0%) | ||
Aurora B | Absent | 3 | (27.3%) | 4 | (17.4%) | 0.653 |
Rare | 6 | (54.5%) | 16 | (69.6%) | ||
Moderate | 2 | (18.2%) | 3 | (13.0%) | ||
Abundant | 0 | (0%) | 0 | (0%) | ||
Centrin 2 | Absent | 2 | (18.2%) | 1 | (4.3%) | 0.235 |
Rare | 2 | (18.2%) | 6 | (26.1%) | ||
Moderate | 5 | (45.5%) | 15 | (65.2%) | ||
Abundant | 2 | (18.2%) | 1 | (4.3%) | ||
Centrin 3 | Absent | 1 | (9.1%) | 1 | (4.3%) | 0.536 |
Rare | 3 | (27.3%) | 3 | (13.0%) | ||
Moderate | 3 | (27.3%) | 5 | (21.7%) | ||
Abundant | 4 | (36.4%) | 14 | (60.9%) |